Credit Suisse Group Analysts Give Vivendi (VIV) a €24.20 Price Target

Credit Suisse Group set a €24.20 ($28.14) price objective on Vivendi (EPA:VIV) in a report issued on Friday. The brokerage currently has a buy rating on the stock.

Several other research firms also recently issued reports on VIV. Kepler Capital Markets set a €21.00 ($24.42) price target on shares of Vivendi and gave the company a neutral rating in a research report on Tuesday, July 31st. Deutsche Bank set a €30.00 ($34.88) price target on shares of Vivendi and gave the company a buy rating in a research report on Tuesday, July 31st. Morgan Stanley set a €28.00 ($32.56) price target on shares of Vivendi and gave the company a buy rating in a research report on Friday, September 7th. Barclays set a €23.00 ($26.74) price target on shares of Vivendi and gave the company a neutral rating in a research report on Tuesday, July 31st. Finally, HSBC set a €25.00 ($29.07) price objective on shares of Vivendi and gave the stock a neutral rating in a report on Wednesday, August 1st. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of €24.96 ($29.02).

EPA VIV opened at €21.72 ($25.26) on Friday. Vivendi has a 12-month low of €16.85 ($19.59) and a 12-month high of €24.87 ($28.92).

Vivendi Company Profile

Vivendi SA operates as a content media and communication company in France, rest of Europe, the United States, and internationally. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment is involved in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provides artist and merchandising services.

Read More: Hedge Funds

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply